X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
apparently healthy-men (637) 637
humans (542) 542
c-reactive protein (423) 423
male (342) 342
female (325) 325
inflammation (300) 300
middle aged (287) 287
risk factors (271) 271
cardiovascular-disease (230) 230
adult (199) 199
atherosclerosis (199) 199
aged (181) 181
myocardial-infarction (173) 173
cardiac & cardiovascular systems (159) 159
coronary-heart-disease (157) 157
peripheral vascular disease (157) 157
biomarkers - blood (155) 155
index medicus (150) 150
c-reactive protein - analysis (123) 123
c-reactive protein - metabolism (121) 121
risk (113) 113
plasma-concentration (98) 98
cardiovascular disease (90) 90
interleukin-6 (88) 88
interleukin-6 - blood (88) 88
prospective studies (77) 77
risk-factors (76) 76
inflammation - blood (72) 72
cardiovascular risk-factors (71) 71
future myocardial-infarction (71) 71
hematology (71) 71
heart-disease (69) 69
coronary heart-disease (67) 67
case-control studies (66) 66
blood-pressure (65) 65
intercellular-adhesion molecule-1 (65) 65
hypertension (64) 64
intercellular adhesion molecule-1 - blood (64) 64
unstable angina (63) 63
acute myocardial-infarction (62) 62
blood pressure (60) 60
insulin-resistance (60) 60
medicine, general & internal (60) 60
animals (57) 57
women (57) 57
prognosis (55) 55
risk assessment (55) 55
body mass index (54) 54
follow-up studies (54) 54
cardiovascular diseases - blood (53) 53
predictive value of tests (53) 53
mortality (51) 51
middle-aged men (49) 49
cardiovascular diseases (48) 48
metabolic syndrome (48) 48
cohort studies (47) 47
low-density-lipoprotein (47) 47
necrosis-factor-alpha (47) 47
coronary heart disease (46) 46
cytokines (46) 46
biomarkers (45) 45
coronary-artery-disease (45) 45
multivariate analysis (45) 45
e-selectin (44) 44
cross-sectional studies (43) 43
endocrinology & metabolism (43) 43
tumor-necrosis-factor (43) 43
obesity (41) 41
disease (40) 40
health aspects (39) 39
artery-disease (38) 38
cardiovascular diseases - epidemiology (38) 38
cardiovascular diseases - etiology (38) 38
cholesterol (37) 37
coronary-artery disease (37) 37
inflammation - complications (37) 37
research (37) 37
medical laboratory technology (36) 36
aged, 80 and over (35) 35
association (34) 34
carotid atherosclerosis (34) 34
vascular cell adhesion molecule-1 - blood (34) 34
acute coronary syndromes (33) 33
adolescent (33) 33
coronary disease - blood (32) 32
endothelial-cells (32) 32
epidemiology (32) 32
hypertension - blood (32) 32
markers (32) 32
endothelial dysfunction (31) 31
heart attacks (31) 31
inflammation - physiopathology (31) 31
physiological aspects (31) 31
proteins (31) 31
medicine, research & experimental (30) 30
analysis (29) 29
events (29) 29
fibrinogen (29) 29
smoking (29) 29
age factors (28) 28
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (627) 627
French (8) 8
Spanish (5) 5
German (4) 4
Russian (4) 4
Japanese (3) 3
Portuguese (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 11/2008, Volume 359, Issue 21, pp. 2195 - 2207
In this trial, 17,802 healthy men and women with low-density lipoprotein cholesterol levels of less than 130 mg per deciliter and high-sensitivity C-reactive... 
MEDICINE, GENERAL & INTERNAL | DENSITY-LIPOPROTEIN CHOLESTEROL | APPARENTLY HEALTHY-MEN | STATIN THERAPY | INFLAMMATION | CARDIOVASCULAR-DISEASE | JUPITER TRIAL | RISK | PRAVASTATIN | CORONARY-HEART-DISEASE | PREDICTION | Myocardial Infarction - epidemiology | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Male | C-Reactive Protein - metabolism | Cardiovascular Diseases - blood | Cardiovascular Diseases - mortality | Cholesterol, LDL - blood | Female | Stroke - epidemiology | Muscular Diseases - chemically induced | Stroke - prevention & control | Double-Blind Method | Kaplan-Meier Estimate | Proportional Hazards Models | Rosuvastatin Calcium | Biomarkers - blood | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Sulfonamides - therapeutic use | Pyrimidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Pyrimidines - adverse effects | Sulfonamides - adverse effects | Diabetes Mellitus - chemically induced | Aged | Fluorobenzenes - adverse effects | Myocardial Infarction - prevention & control | Fluorobenzenes - therapeutic use | Prevention | Usage | C-reactive protein | Rosuvastatin | Cardiovascular diseases | Drug therapy | Health aspects | Proteins | Cardiovascular disease | Heart attacks | Cholesterol | Statins | Index Medicus | Abridged Index Medicus
Journal Article
European Heart Journal, ISSN 0195-668X, 07/2014, Volume 35, Issue 27, pp. 1782 - 1791
Atherothrombosis is no longer considered solely a disorder of lipoprotein accumulation in the arterial wall. Rather, the initiation and progression of... 
Darapladib | Atherosclerosis | Inflammasome | Inflammation | Colchicine | Salsalate | C reactive protein | Canakinumab | Methotrexate | Interleukin-6 | C-REACTIVE PROTEIN | FUTURE MYOCARDIAL-INFARCTION | CARDIAC & CARDIOVASCULAR SYSTEMS | INTERLEUKIN-1 RECEPTOR ANTAGONIST | RANDOMIZED CLINICAL-TRIAL | SECRETORY PHOSPHOLIPASE A | ACUTE CORONARY SYNDROME | APPARENTLY HEALTHY-MEN | REVERSE CHOLESTEROL TRANSPORT | PLACEBO-CONTROLLED TRIAL | TYPE-2 DIABETES-MELLITUS | Hydroxychloroquine - therapeutic use | Interleukin-6 - antagonists & inhibitors | NLR Family, Pyrin Domain-Containing 3 Protein | Colchicine - therapeutic use | Humans | Cell Adhesion Molecules - antagonists & inhibitors | Methotrexate - therapeutic use | Sirtuins - therapeutic use | Vaccination - methods | Lipoproteins, HDL - drug effects | Interleukin-1 - physiology | Interleukin-6 - physiology | Anti-Inflammatory Agents - therapeutic use | Interleukin-1 - antagonists & inhibitors | Leukotriene Antagonists - therapeutic use | Carrier Proteins - physiology | Adaptive Immunity - physiology | Phospholipase A2 Inhibitors - therapeutic use | Atherosclerosis - drug therapy | Serpins - therapeutic use | C-Reactive Protein - physiology | Antioxidants - therapeutic use | Tumor Necrosis Factor-alpha - drug effects | Signal Transduction - drug effects | Tumor Necrosis Factor-alpha - physiology | Thrombosis - drug therapy | Receptors, Interleukin-1 - antagonists & inhibitors | Review
Journal Article
Circulation, ISSN 0009-7322, 12/2012, Volume 126, Issue 23, pp. 2739 - 2748
Journal Article